| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MED.20142 |
| P698 | PubMed publication ID | 18855890 |
| P2093 | author name string | Duane D Miller | |
| Dong Jin Hwang | |||
| Michael L Mohler | |||
| Yali He | |||
| Zhongzhi Wu | |||
| P2860 | cites work | Role of AMP-activated protein kinase in mechanism of metformin action | Q22241898 |
| Fructose-2,6-bisphosphate and control of carbohydrate metabolism in eukaryotes | Q28143816 | ||
| Pharmacologic therapy for type 2 diabetes mellitus | Q33716414 | ||
| Risk factors for type 2 diabetes mellitus | Q34500042 | ||
| Prospects for pharmacologic inhibition of hepatic glucose production | Q35060999 | ||
| Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration | Q35605156 | ||
| Therapeutic potential of retinoid x receptor modulators for the treatment of the metabolic syndrome | Q35753018 | ||
| Glucose transporter and Na+/glucose cotransporter as molecular targets of anti-diabetic drugs | Q35950011 | ||
| Selective modulators of PPAR activity as new therapeutic tools in metabolic diseases. | Q36447480 | ||
| Selective Modulators of PPAR-gamma Activity: Molecular Aspects Related to Obesity and Side-Effects | Q36772301 | ||
| AMP activated protein kinase: a next generation target for total metabolic control. | Q37030884 | ||
| Treatment of diabetic foot ulcer: an overview strategies for clinical approach | Q37065721 | ||
| Glitazones and the cardiovascular system | Q37100831 | ||
| Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy. | Q39802111 | ||
| PPAR: a mediator of peroxisome proliferator action | Q40933278 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 125-195 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Medicinal Research Reviews | Q2436033 |
| P1476 | title | Recent and emerging anti-diabetes targets | |
| P478 | volume | 29 |
| Q39113371 | Adenosine Monophosphate (AMP)-Activated Protein Kinase: A New Target for Nutraceutical Compounds |
| Q47111998 | An Integrated Computational Approach for Plant-Based Protein Tyrosine Phosphatase Non-Receptor Type 1 Inhibitors |
| Q45185400 | CoMFA and CoMSIA studies on C-aryl glucoside SGLT2 inhibitors as potential anti-diabetic agents |
| Q39159232 | Design, Synthesis, and in Vitro Evaluation of Novel Aminomethyl-pyridines as DPP-4 Inhibitors |
| Q47838652 | Diabetes area patent participation analysis - part II: years 2011-2016. |
| Q35686202 | Diabetes: time to look beyond gluttony and laziness |
| Q35205907 | Fructose-fed rhesus monkeys: a nonhuman primate model of insulin resistance, metabolic syndrome, and type 2 diabetes |
| Q38110276 | Ginseng and diabetes: the evidences from in vitro, animal and human studies |
| Q41726958 | ISN Forefronts Symposium 2015: Nuclear Receptors and Diabetic Nephropathy |
| Q50738845 | In silico modelling and molecular dynamics simulation studies of thiazolidine based PTP1B inhibitors. |
| Q53588308 | Low-energy collision-induced dissociation mass spectra of protonated p-toluenesulfonamides derived from aliphatic amines. |
| Q37914071 | Mechanism of action of natural products used in the treatment of diabetes mellitus. |
| Q28081094 | Modulation of glucose transporter protein by dietary flavonoids in type 2 diabetes mellitus |
| Q27675984 | Molecular Determinants of Magnolol Targeting Both RXRα and PPARγ |
| Q26830869 | Natural products possessing protein tyrosine phosphatase 1B (PTP1B) inhibitory activity found in the last decades |
| Q42396790 | Pharmacotherapy-Based Problems in the Management of Diabetes Mellitus: Needs Much More to be Done! |
| Q28478635 | Predicting biological functions of compounds based on chemical-chemical interactions |
| Q42554440 | Renal glucose handling in diabetes and sodium glucose cotransporter 2 inhibition |
| Q37872125 | SGLT2 inhibitors: a new emerging therapeutic class in the treatment of type 2 diabetes mellitus |
| Q47700645 | Use of SGLT-2 inhibitors in the treatment of type 2 diabetes mellitus |
Search more.